Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DNA polymerase sequencing

Executive Summary

Cleveland, Ohio-based U.S. Biochemical and Harvard University file suit in a New Jersey federal court against Swedish company Pharmacia AB and its U.S. subsidiaries to stop use of T7 DNA polymerase-based sequencing technology in DNA sequencing kits and related products. Covered by a patent issued to Harvard and licensed to U.S. Biochemical, T7 DNA polymerase-based sequencing products are now marketed under the brandname Sequenase.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS016026

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel